以質性研究方式探討臺灣藥師對藥品仿單查詢平台之使用意願

Abstract

仿單為藥品附加之說明書，提供藥品有效性、安全性及品質之相關資訊。臺灣的醫療現況是以給醫護人員參閱之紙本仿單為主，經歷仿單電子化與結構化後於2022年5月架設完成藥品仿單查詢平台作為電子結構化仿單的資料庫，若要更進一步施行仿單無紙化，建立完善且讓人具使用意願的查詢平台是必要的基礎，本研究以質性方法來了解藥師們對藥品仿單查詢平台上藥品仿單資訊頁面的看法，以及仿單無紙化預計帶來的衝擊。 本研究為便利取樣，於2024年1月至2024年02月間透過google表單於Facebook以及Line群組，招募具中華民國藥師執業執照、具調劑經驗且查詢仿單頻率為每兩週一次以上之藥師，最終收納14位研究參與者進行實體一對一訪談或焦點團體。 研究結果使用架構分析法結合更新版Delone and Mclean資訊系統成功模型 (D&M IS Success Model)來檢視，發現藥師對藥品仿單查詢平台的使用意願主要受系統品質與資訊品質影響，其中系統品質的結構化與資訊品質的完整性、易讀性與即時性，會提高藥師對藥品仿單查詢平台的使用意願；其他增加使用意願的因素還有建置完全的「藥品外觀」功能、更精準的「與前一版比對」功能，以及未來若施行仿單無紙化所帶來的環保效益。另外，未來若擴增至處方藥品全品項無紙化，預期對藥師執業影響不大，唯執業場所需對管理紙本仿單有相應措施。

Package inserts (PIs) are additional documents accompanying medications that offers essential information on efficacy, safety, and quality of the medications. In Taiwan’s current medical condition, printed PIs primarily serve as references for healthcare personnel. Following the digitization and structuring of these PIs, a medication package insert query platform was launched in May 2022, establishing a database for electronic structured PIs. To further support the transition to a paper-free system for PIs, it is critical to develop a comprehensive and user-friendly search platform. This study used qualitative methods to understand pharmacists’ views on the medication PI information pages on this platform, and the anticipated impacts of the e-labelng policy. This study utilized convenience sampling to recruit pharmacists with a valid Taiwan pharmacist license, dispensing experience, and a frequency of looking up PIs of at least biweekly. The recruitment was conducted via Google Forms on Facebook and Line groups from January 2024 to February 2024, ultimately enrolling 14 participants for individual in-person interviews or focus groups. The results were examined using the framework analysis method combined with the Updated Delone and Mclean Information System Success Model (D&M IS Success Model). It was found that pharmacists' willingness to use the platform was primarily influenced by system quality and information quality. Specifically, the structured data of system quality and the completeness, readability, and timeliness of information quality were key factors that increased pharmacists' willingness to use the platform. Additional factors that enhanced usage willingness included the implementation of a comprehensive "drug appearance" feature, a more accurate "version comparison" function, and the environmental benefits associated with future e-labeling. Furthermore, the anticipated expansion to a fully paper-free system for all prescription drugs is expected to have minimal impact on pharmacists' practice. However, appropriate measures for managing paper format PIs would need to be implemented at practice locations.